• Sexually transmitted infections, including HIV, in the Netherlands in 2006

      MG van Veen; FDH Koedijk; IVF van der Broek; ELM Op de Coul; IM de Boer; AI van Sighem; MAB van der Sande; soa-centra; Stichting HIV Monitoring; EPI/Cib (Rijksinstituut voor Volksgezondheid en Milieu RIVM, 2007-11-26)
      The nationally covered low threshold STI centres offering STI care targeted at high risk groups, provide surveillance data to monitor national trends in STI, including HIV. In 2006, chlamydia remained the most commonly diagnosed bacterial STI in the Netherlands in the STI centres, in spite of stabilizing trends in MSM and heterosexual men. The majority of chlamydia diagnoses were made in young heterosexuals. The decreasing trend in diagnoses of gonorrhoea (in heterosexuals) and syphilis continued further in 2006. Both infections were most prevalent among MSM. Additionally, a new increase in LGV diagnoses was observed among MSM, indicating that continued awareness is needed. As of June 2007, a cumulative total of 13,086 HIV cases, under medical care, had been recorded in the Netherlands. In 2006, 871 new cases were recorded in the national HIV registry of the HMF. The proportion of MSM among HIV cases reporting for care increased again in 2006. Concurrent STI were often diagnosed among HIV positive MSM visiting STI centres. Continuing STI and HIV transmission in this high risk group warrants intensified and innovative interventions. As in previous years, specific ethnic minorities (for instance from Surinam, the Netherlands Antilles and Aruba) had higher positivity rates for genital chlamydial infection, gonorrhoea and syphilis (heterosexual men) than autochthonous Dutch, indicating the need for targeted intervention by risk profile. Furthermore, the majority of HIV infected heterosexuals entering in care, reported to have acquired their infection abroad. In 2006, the percentage of ciprofloxacin resistance in gonococci further increased up to 38% (among MSM 45 %). So far, resistance to cephalosporins, current recommended first line therapy, has not yet been recorded. Alertness remains indicated.